Menopause Hormone Therapy (HRT) in Lancaster, PA

Bioidentical hormones in Lancaster: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

Many products sold as "bioidentical hormones" or "BHRT" are compounded instead: mixed by a pharmacy for one prescription, often as a custom cream or a pellet. None of these is FDA-approved, and the FDA has not reviewed them for safety, effectiveness or quality before sale. In the FDA's words, it has no evidence that compounded "bioidentical hormones" are safe and effective. When the National Academies reviewed them in 2020, the evidence was mostly low quality, such as anecdotes and patient reports.

You do not choose a "bioidentical" product from a menu: after a private intake, a physician licensed in Pennsylvania decides what, if anything, fits, and the form. VevaMD does not offer pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

The NPI registry counts 53 OB-GYNs practicing in Lancaster, about 91.9 for every 100,000 residents against 17.8 nationally and above Pennsylvania's 20.0, a higher rate than 96% of the cities VevaMD covers. Set against the city's 6,624 women aged 45 to 64, that is one OB-GYN for roughly every 120.

Counting the area around it, 63 OB-GYNs practice in Lancaster or within 10 miles and 254 within 25 miles: 24.4 for every 100,000 of the 1,043,073 people who live within 25 miles, a dense supply. VevaMD is an online option alongside them: a physician licensed in Pennsylvania reviews your intake from Lancaster without an office visit, and an OB-GYN you already see stays your doctor.

BHRT pellet clinics work differently: they place a hormone pellet under the skin in the office, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11